These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 34724662)

  • 1. Macrophage-Biomimetic Nanoparticles Ameliorate Ulcerative Colitis through Reducing Inflammatory Factors Expression.
    Li Z; Zhang X; Liu C; Peng Q; Wu Y; Wen Y; Zheng R; Yan Q; Ma J
    J Innate Immun; 2022; 14(4):380-392. PubMed ID: 34724662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Delivery of Nanoparticles Loaded With Ginger Active Compound, 6-Shogaol, Attenuates Ulcerative Colitis and Promotes Wound Healing in a Murine Model of Ulcerative Colitis.
    Zhang M; Xu C; Liu D; Han MK; Wang L; Merlin D
    J Crohns Colitis; 2018 Jan; 12(2):217-229. PubMed ID: 28961808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colon-targeted delivery of cyclosporine A using dual-functional Eudragit
    Naeem M; Bae J; Oshi MA; Kim MS; Moon HR; Lee BL; Im E; Jung Y; Yoo JW
    Int J Nanomedicine; 2018; 13():1225-1240. PubMed ID: 29535519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.
    Shrestha N; Xu Y; Prévost JRC; McCartney F; Brayden D; Frédérick R; Beloqui A; Préat V
    Acta Biomater; 2022 Mar; 140():561-572. PubMed ID: 34923097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer.
    Yang M; Zhang F; Yang C; Wang L; Sung J; Garg P; Zhang M; Merlin D
    J Crohns Colitis; 2020 Jan; 14(1):130-141. PubMed ID: 31168612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of ulcerative colitis
    Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
    Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PepT1 mediated medicinal nano-system for targeted delivery of cyclosporine A to alleviate acute severe ulcerative colitis.
    Wu Y; Sun M; Wang D; Li G; Huang J; Tan S; Bao L; Li Q; Li G; Si L
    Biomater Sci; 2019 Oct; 7(10):4299-4309. PubMed ID: 31408067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease.
    Lautenschläger C; Schmidt C; Lehr CM; Fischer D; Stallmach A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):578-86. PubMed ID: 24084650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colitis-targeted hybrid nanoparticles-in-microparticles system for the treatment of ulcerative colitis.
    Naeem M; Lee J; Oshi MA; Cao J; Hlaing SP; Im E; Jung Y; Yoo JW
    Acta Biomater; 2020 Oct; 116():368-382. PubMed ID: 32937207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic Acid-Conjugated PLGA Nanoparticles Alleviate Ulcerative Colitis via CD44-Mediated Dual Targeting to Inflamed Colitis Tissue and Macrophages.
    Hlaing SP; Cao J; Lee J; Kim J; Saparbayeva A; Kwak D; Kim H; Hwang S; Yun H; Moon HR; Jung Y; Yoo JW
    Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Functional Eudragit
    Gao C; Yu S; Zhang X; Dang Y; Han DD; Liu X; Han J; Hui M
    Int J Nanomedicine; 2021; 16():1405-1422. PubMed ID: 33658780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
    Xiao B; Si X; Zhang M; Merlin D
    Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis.
    Xiao B; Xu Z; Viennois E; Zhang Y; Zhang Z; Zhang M; Han MK; Kang Y; Merlin D
    Mol Ther; 2017 Jul; 25(7):1628-1640. PubMed ID: 28143741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Molecular Targeted Immunotherapeutic Strategy for Ulcerative Colitis via Dual-targeting Nanoparticles Delivering miR-146b to Intestinal Macrophages.
    Deng F; He S; Cui S; Shi Y; Tan Y; Li Z; Huang C; Liu D; Zhi F; Peng L
    J Crohns Colitis; 2019 Mar; 13(4):482-494. PubMed ID: 30445446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium pectinate and hyaluronic acid modified lactoferrin nanoparticles loaded rhein with dual-targeting for ulcerative colitis treatment.
    Luo R; Lin M; Fu C; Zhang J; Chen Q; Zhang C; Shi J; Pu X; Dong L; Xu H; Ye N; Sun J; Lin D; Deng B; McDowell A; Fu S; Gao F
    Carbohydr Polym; 2021 Jul; 263():117998. PubMed ID: 33858583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-in-one theranostic nano-platform based on polymer nanoparticles for BRET/FRET-initiated bioluminescence imaging and synergistically anti-inflammatory therapy for ulcerative colitis.
    Yan X; Yang C; Yang M; Ma Y; Zhang Y; Zhang Y; Liu C; Xu Q; Tu K; Zhang M
    J Nanobiotechnology; 2022 Mar; 20(1):99. PubMed ID: 35236359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural-lipid nanoparticle-based therapeutic approach to deliver 6-shogaol and its metabolites M2 and M13 to the colon to treat ulcerative colitis.
    Yang C; Zhang M; Lama S; Wang L; Merlin D
    J Control Release; 2020 Jul; 323():293-310. PubMed ID: 32335157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fab'-bearing siRNA TNFα-loaded nanoparticles targeted to colonic macrophages offer an effective therapy for experimental colitis.
    Laroui H; Viennois E; Xiao B; Canup BS; Geem D; Denning TL; Merlin D
    J Control Release; 2014 Jul; 186():41-53. PubMed ID: 24810114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease.
    Beloqui A; Coco R; Memvanga PB; Ucakar B; des Rieux A; Préat V
    Int J Pharm; 2014 Oct; 473(1-2):203-12. PubMed ID: 25014369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.